Latest "Cell Signaling Technologies" News Stories

11:09 EDT 19th July 2018 | BioPortfolio

Here are the most relevant search results for "Cell Signaling Technologies" found in our extensive news archives from over 250 global news sources.

More Information about Cell Signaling Technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cell Signaling Technologies for you to read. Along with our medical data and news we also list Cell Signaling Technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cell Signaling Technologies Companies for you to search.

Showing "Cell Signaling Technologies" News Articles 1–25 of 12,000+


Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells

Expression of the B-cell antigen receptor (BCR) is essential not only for the development but also for the maintenance of mature B cells. Similarly, many B-cell lymphomas, including Burkitt lymphoma (BL), require continuous BCR signaling for their tumor growth. This growth is driven by immunoreceptor tyrosine-based activation motif (ITAM) and PI3 kinase (PI3K) signaling. Here, we employ CRISPR/Cas...

Graphene Could Strengthen Nerve Signaling in the Brain

ArticleGraphene could hold the key to increasing the strength of nerve cell signaling and enabling nerve cell membranes to pull in more cholesterol.

Uncovering a hidden protein 'tail' that puts the brakes on cell signaling

(Georgia Institute of Technology) Using an informatics tool that identifies "hotspots" of post-translational modification (PTM) activity on proteins, researchers have found a previously-unknown mechanism that puts the brakes on an important cell signaling process involving the G proteins found in most living organisms.

Stem Cell Sciences: Stem Cell Technologies: The End of the Beginning

In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research applications. The company is now at the ‘end of the beginning stage’, and has the capability to mass produce stem cells, with which it hopes to provide a range of products and services. The impact ...

Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival

Non-cell-autonomous function of DR6 in Schwann cell proliferation

Death receptor 6 (DR6) is an orphan member of the TNF receptor superfamily and controls cell death and differentiation in a cell-autonomous manner in different cell types. Here, we report an additional non-cell-autonomous function for DR6 in the peripheral nervous system (PNS). DR6-knockout (DR6 KO) mice showed precocious myelination in the PNS. Using an in vitro myelination assay, we demonst...

CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis

Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion

The Fos-related antigen 1 (FRA-1) transcription factor promotes tumor cell growth, invasion and metastasis. Phosphorylation of FRA-1 increases protein stability and function. We identify a novel signaling axis...

Corvus Pharmaceuticals Announces Presentation of New Data from Preclinical Study of Novel T-Cell Signaling Pathway Inhibitor at 10th Annual T-Cell Lymphoma Forum

BURLINGAME, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies, today announced new data from an ongoing preclinical study of its investigational small molecule T-cell signaling pathway inhibitor. Results showed that this orall...

Living Cell Technologies: New Technologies and Clinical Trials

In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Paul Tan, CEO of Living Cell Technologies. Filmed at AusBiotech 2009, they discuss: • The company’s origins and aims • Pig islet transplantation to combat diabetes • Results of Russian and New Zealand clinical trials • Living Cell Technologies’ issues with clinical trials in Australia • The company’s searc...

Cell-Based Cancer Therapy Prodded by Custom IL-2 Keeps Going and Going

Whether you spare the rod or wield it freely, you risk spoiling the cell-based cancer therapy. The rod in this case is interleukin-2 (IL-2), a signaling chemical that awakens T cells to their cancer-fighting duties. Letting up on the IL-2 allows T cells to err on the side of sloth. Persistent administration, however, raises the risks of serious side effects. To circumvent this dilemma, scienti...

Interplay of cell-cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identity

Cell–cell and cell–matrix interactions guide organ development and homeostasis by controlling lineage specification and maintenance, but the underlying molecular principles are largely unknown. Here, we show that in human developing cardiomyocytes cell–cell contacts at the intercalated disk connect to remodeling of the actin cytoskeleton by regulating the RhoA-ROCK signaling to m...

A Novel Immortalized Human Adrenal Cell Line with Inactive Protein Kinase A for Studies on cAMP Signaling and Endocrine Tumorigenesis

The first known immortalized cell line with a naturally-occurring inactivating mutation in PRKAR1A, the regulatory subunit type 1A (R1alpha) of protein kinase A (PKA), which is associated with tumor formation.Read more about A Novel Immortalized Human Adrenal Cell Line with Inactive Protein Kinase A for Studies on cAMP Signaling and Endocrine Tumorigenesis

T cell antigen receptors act alone: Longstanding immunological mystery solved

(Vienna University of Technology) With a standard electron microscope, only dead T cells can be studied. Therefore, it is very hard to figure out the inner workings of the cell. New microscopy techniques, making it possible to study living T cells, have now led to surprising results: while it has been generally believed that T cell receptors must interact with one another for effective immune-sign...

Immunology Research Set to Change after Study Shows T-Cell Antigen Receptors Act Alone

Researchers at TU Wien and the Vienna School of Medicine report that T-cell receptors act alone, rather than interact with one another, for effective immune signaling. Their study (“ Monomeric TCRs drive T cell antigen recognition ”) appears in  Nature Immunology . “T-cell antigen recognition requires T cell antigen receptors (TCRs) engaging MHC-embedded antigenic peptides (pMH...

Targeting Colon Cancer Plasticity May Prevent Drug Resistance

Scientists in Germany have discovered that colon cancers contain two different cell types, characterized by mitogen-activated protein kinase (MAPK) and NOTCH signaling, respectively, which can regenerate each other when one type is killed by a targeted therapeutic. The studies, headed by David Horst, Ph.D., at the Charité University Hospital in Berlin, suggest that this cell plasticity allow...

Lesson 9 Cell Signaling: Curations and Articles of reference as supplemental information for lecture section on WNTs: #TUBioll3373

Lesson 9 Cell Signaling:  Curations and Articles of reference as supplemental information for lecture section on WNTs: #TUBiol3373 Stephen J. Wiilliams, Ph.D: Curator The following contain curations of scientific articles from the site  intended as additional reference material  to supplement material presented in the lecture. Wnts are a family of lipid-mo...

Spaceflight activates cell changes with implications for stem cell-based heart repair

(Mary Ann Liebert, Inc./Genetic Engineering News) A new study of the effects of spaceflight on the development of heart cells identified changes in calcium signaling that could be used to develop stem cell-based therapies for cardiac repair.

Researchers use 'top-down proteomics' strategy to get new insights into cancer

When a RAS gene operates normally, it acts as an on/off switch for cell signaling to control cell proliferation. But when the gene mutates, the switch jams into the "on" position, allowing cells to proliferate uncontrollably.

CiteAb Names Cell Signaling Technology Antibody Company of the Year

“Antibody Company of the Year” and “Antibody Company Succeeding in Cancer Biology" DANVERS, Mass. (PRWEB) February 15, 2018 Cell Signaling Technology. Inc. (CST), a leading provider of antibodies, kits, and services, is honored with the 2018 CiteAb Award for “Antibody Company of the Year” and “Antibody Company Succeeding in Cancer Biology.” CST was also highly commended for the...

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

Chemogenetic control of gene expression and cell signaling with antiviral drugs

Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP3 receptor disruptor BIRD-2

Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin

Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma

Quick Search


News Quicklinks